The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Amryt Pharma plc | Common | 03217L106 | 32,160 | 2,668,845 | SH | SOLE | 2,668,845 | 0 | 0 | ||
| Dyne Therapeutics, Inc. | Common | 26818M108 | 80,409 | 4,951,303 | SH | SOLE | 4,951,303 | 0 | 0 | ||
| Harpoon Therapeutics, Inc. | Common | 41358P106 | 24,738 | 3,131,388 | SH | SOLE | 3,131,388 | 0 | 0 | ||
| iTeos Therapeutics, Inc. | Common | 46565G104 | 88,849 | 3,290,711 | SH | SOLE | 3,290,711 | 0 | 0 | ||
| Oncorus, Inc. | Common | 68236R103 | 26,614 | 2,849,464 | SH | SOLE | 2,849,464 | 0 | 0 | ||
| Repare Therapeutics, Inc. | Common | 760273102 | 58,847 | 2,242,636 | SH | SOLE | 2,242,636 | 0 | 0 | ||
| Rhythm Pharmaceuticals, Inc. | Common | 76243J105 | 11,875 | 909,258 | SH | SOLE | 909,258 | 0 | 0 | ||
| TCR2 Therapeutics, Inc. | Common | 87808K106 | 34,473 | 4,050,865 | SH | SOLE | 4,050,865 | 0 | 0 | ||
| Werewolf Therapeutics, Inc. | Common | 95075A107 | 73,516 | 4,284,172 | SH | SOLE | 4,284,172 | 0 | 0 | ||